LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (LXRX)

CUSIP: 528872302

Q2 2026 13F Holders as of 30 Jun 2026

Holder snapshot 5 signals
Share change
+957
SEC-reported price per share
$2.40
Number of holders
1
Value change
+$2,297
Number of buys
1
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
444,558,533

Security key

528872302

Report period

Q2 2026

Institutions

1

Top holders

1

Ownership snapshot

Top reported holders of LXRX - LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Invus Global Management, LLC
Disclosed value leader
Artal Participations S.a ...
Comparable rows
15/15
Latest evidence
30 Apr 2026
13D/G 3/4/5 13F Lead comparable stake: 39% 13D/G row: Invus Global Management, LLC Showing 1-6 of 15 holder rows.

Quick read

Invus Global Management, LLC leads the comparable SEC ownership view at 39%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Invus Global Management, LLC's linked filing trail.
Comparable ownership Top 5
Invus Global Management, LLC 39%
FMR LLC 10%
Artal Participations S.a r.l. 39%
Administratiekantoor Westend Stic... 39%
Amaury Wittouck 39%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Invus Global Management, LLC
13D/G 3/4/5
Artal Participations S.a r.l. · Director, 10%+ Owner
39%
$273,243,457
175,156,062 shares
+$31,857,907 30 Apr 2026
FMR LLC
13F 13D/G
Company
10%
from 13D/G
$70,287,887
45,056,338 shares
31 Mar 2026
Artal Participations S.a r.l.
3/4/5
Director, 10%+ Owner
39%
$299,791,711
175,156,062 shares
mixed-class rows
30 Apr 2026
Administratiekantoor Westend Stichting
3/4/5
Director, 10%+ Owner
39%
$273,243,456
175,156,062 shares
30 Apr 2026
Amaury Wittouck
3/4/5
Director, 10%+ Owner
39%
$273,243,456
175,156,062 shares
30 Apr 2026
Artal Group S.A.
3/4/5 13F
Director, 10%+ Owner · Company
39%
$273,243,456
175,156,062 shares
30 Apr 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
1
Shares
957
Rows available
1
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders
134
Q2 2026 holders
1
Holder diff
-133
Investor Q1 2026 Shares Q2 2026 Shares Share Diff Share Chg % Q1 2026 value Q2 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .